Kocakavuk, Emre http://orcid.org/0000-0003-1920-0494
Anderson, Kevin J. http://orcid.org/0000-0002-2362-273X
Varn, Frederick S. http://orcid.org/0000-0001-6307-016X
Johnson, Kevin C. http://orcid.org/0000-0003-0016-5158
Amin, Samirkumar B.
Sulman, Erik. P. http://orcid.org/0000-0003-4933-9120
Lolkema, Martijn P. http://orcid.org/0000-0003-0466-2928
Barthel, Floris P. http://orcid.org/0000-0002-7425-4180
Verhaak, Roel G. W. http://orcid.org/0000-0003-2773-0436
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R21 NS114873)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA034196, CA226387)
U.S. Department of Defense (W81XWH1910246)
Article History
Received: 18 September 2020
Accepted: 21 April 2021
First Online: 27 May 2021
Competing interests
: R.G.W.V. is a co-founder of Boundless Bio, Inc., which was not involved in the research presented here. R.G.W.V. is a member of the Scientific Advisory Board of the HMF. F.P.B. has performed consulting for Bristol Myers Squibb. R.G.W.V., E.K., K.J.A. and F.P.B. are listed as inventors on a patent application filed by The Jackson Laboratory, related to the findings described here. The remaining authors declare no competing interests.